
FIGS (FIGS) Stock Forecast & Price Target
FIGS (FIGS) Analyst Ratings
Bulls say
FIGS is expected to continue to see growth and margin expansion, thanks to strong momentum and potential for further growth in expansion areas domestically and internationally. With an Overweight rating, their strong brand and unique products give them an advantage over competitors. Their solid financial position allows for investments in growth initiatives and potential for shareholder returns, as they expand their product offerings and aim to become a lifestyle brand in the healthcare apparel industry. The company's maximum revenue is generated from the sale of scrubwear products and they are well-positioned in the US market and are also actively expanding globally, making them a strong player in the industry.
Bears say
FIGS is a popular healthcare apparel company with a strong direct-to-consumer digital platform and a growing network of physical retail stores. However, the high trading multiple of ~35.4x based on the analyst's 2026 adjusted EBITDA estimate of $113 million raises concerns about the sustainability of the company's growth momentum. Additionally, risks such as volatility in the macroeconomic environment, tariffs, and competition from new entrants with considerable financial resources could hinder the company's future performance. Overall, these factors contribute to a negative outlook on FIGS's stock as an investment opportunity.
This aggregate rating is based on analysts' research of FIGS and is not a guaranteed prediction by Public.com or investment advice.
FIGS (FIGS) Analyst Forecast & Price Prediction
Start investing in FIGS (FIGS)
Order type
Buy in
Order amount
Est. shares
0 shares